The rise of GLP-1 medications is influencing the way people eat. Appetite patterns are changing, portions are becoming smaller and consumers are looking for more value in every bite. For food manufacturers, this opens a new space for innovation: products that combine nutrition, taste, texture and indulgence in smarter, more balanced formats.